Julie Graff, MD, assistant professor of medicine, OHSU Knight Cancer Institute, discusses the treatment of prostate cancer.
Julie Graff, MD
Advertisement
Articles by Julie Graff, MD
Julie Graff, MD, assistant professor of medicine, OHSU Knight Cancer Institute, discusses the role of checkpoint inhibitors and PARP inhibitors for patients with prostate cancer.
Julie Graff, MD, assistant professor of medicine, OHSU Knight Cancer Institute, discusses sipuleucel-T (Provenge) in patients with metastatic castration-resistant prostate cancer.
Advertisement
Latest Updated Articles
Dr. Graff Discusses Sipuleucel-T in Patients With mCRPCDecember 8th 2017
Dr. Graff on the Role of Checkpoint Inhibitors in Prostate CancerDecember 26th 2017
Dr. Graff Discusses the Treatment of Prostate CancerJanuary 9th 2018
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5